S. V. Konstantinides, A. Torbicki, G. Agnelli, N. Danchin, D. Fitzmaurice et al.,

, ESC guidelines on the diagnosis and management of acute pulmonary embolism, Eur Heart J, vol.35, issue.43, pp.3069-3069, 2014.

E. K. Zern, M. N. Young, K. Rosenfield, and C. Kabrhel, A Pulmonary Embolism Response Team: initial experiences and future directions, Expert Rev Cardiovasc Ther. juin, vol.15, issue.6, pp.481-490, 2017.

N. S. Gibson, M. Sohne, M. Kruip, L. W. Tick, V. E. Gerdes et al., Further validation and simplification of the Wells clinical decision rule in pulmonary embolism, Thromb Haemost. janv, vol.99, issue.1, pp.229-263, 2008.

F. A. Klok, I. Mos, M. Nijkeuter, M. Righini, A. Perrier et al., Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism, Arch Intern Med, vol.168, pp.2131-2137, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00685583

G. C. Digby, P. Kukla, Z. Zhan, C. A. Pastore, R. Piotrowicz et al., The value of electrocardiographic abnormalities in the prognosis of pulmonary embolism: a consensus paper, Ann Noninvasive Electrocardiol Off J Int Soc Holter Noninvasive Electrocardiol Inc. mai, vol.20, issue.3, pp.207-230, 2015.

L. Linkins, T. Lapner, and S. , Review of D-dimer testing: Good, Bad, and Ugly, Int J Lab Hematol. mai, vol.39, issue.1, pp.98-103, 2017.

T. Suzuki, A. Lyon, R. Saggar, L. M. Heaney, K. Aizawa et al., Editor's

, Choice-Biomarkers of acute cardiovascular and pulmonary diseases, Eur Heart J Acute Cardiovasc Care. sept, vol.5, issue.5, pp.416-449, 2016.

M. Righini, J. Van-es, D. Exter, P. L. Roy, P. Verschuren et al., Ageadjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study, JAMA. 19 mars, vol.311, issue.11, pp.1117-1141, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01027476

P. Roy, I. Colombet, P. Durieux, G. Chatellier, H. Sors et al., Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism, BMJ. 30 juill, vol.331, issue.7511, p.259, 2005.

M. Righini, L. Gal, G. Aujesky, D. Roy, P. Sanchez et al., Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial, Lancet Lond Engl. 19 avr, vol.371, issue.9621, pp.1343-52, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00685470

C. O'connell, Incidentally found pulmonary embolism: what's the clinician to do?, Hematol Am Soc Hematol Educ Program, vol.2015, pp.197-201, 2015.

F. A. Klok and M. V. Huisman, Management of incidental pulmonary embolism, Eur Respir J, issue.6, p.49, 2017.

T. Van-der-hulle, C. Dronkers, F. A. Klok, and M. V. Huisman, Recent developments in the diagnosis and treatment of pulmonary embolism, J Intern Med. janv, vol.279, issue.1, pp.16-29, 2016.

R. D. Hull, J. Hirsh, C. J. Carter, R. M. Jay, P. E. Dodd et al., Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan, Ann Intern Med. juin, vol.98, issue.6, pp.891-900, 1983.

N. J. Giordano, P. S. Jansson, M. N. Young, K. A. Hagan, and C. Kabrhel, Epidemiology, Pathophysiology, Stratification, and Natural History of Pulmonary Embolism, Tech Vasc Interv Radiol. sept, vol.20, issue.3, pp.135-175, 2017.

M. Righini, P. Roy, G. Meyer, F. Verschuren, D. Aujesky et al., The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism, J Thromb Haemost JTH, vol.9, issue.10, pp.2115-2122, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00677151

S. Barco, M. Lankeit, H. Binder, S. Schellong, M. Christ et al., Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial, Thromb Haemost, vol.04, issue.1, pp.191-198, 2016.

D. Aujesky, P. Roy, F. Verschuren, M. Righini, J. Osterwalder et al., Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial, Lancet Lond Engl. 2 juill, vol.378, issue.9785, pp.41-49, 2011.

A. Bajaj, M. Saleeb, P. Rathor, V. Sehgal, B. Kabak et al., Prognostic value of troponins in acute nonmassive pulmonary embolism: A meta-analysis, Heart Lung J Crit Care. août, vol.44, issue.4, pp.327-361, 2015.

E. Giannitsis and H. A. Katus, Biomarkers for Clinical Decision-Making in the Management of Pulmonary Embolism, Clin Chem. janv, vol.63, issue.1, pp.91-100, 2017.

O. E. Dahl and M. V. Huisman, Dabigatran etexilate: advances in anticoagulation therapy, Expert Rev Cardiovasc Ther. juin, vol.8, issue.6, pp.771-775, 2010.

E. Investigators, H. R. Büller, M. H. Prins, A. Lensin, H. Decousus et al., Oral rivaroxaban for the treatment of symptomatic pulmonary embolism, N Engl J Med. 5 avr, vol.366, issue.14, pp.1287-97, 2012.

G. Agnelli, H. R. Buller, A. Cohen, M. Curto, A. S. Gallus et al., Oral apixaban for the treatment of acute venous thromboembolism, N Engl J Med. 29 août, vol.369, issue.9, pp.799-808, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00932477

-. Hokusai, . Investigators, H. R. Büller, H. Décousus, M. A. Grosso et al.,

S. Middeldorp, Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism, N Engl J Med, vol.369, issue.15, pp.1406-1421, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00934782

R. Limbrey and L. Howard, Developments in the management and treatment of pulmonary embolism, Eur Respir Rev Off J Eur Respir Soc. sept, vol.24, issue.137, pp.484-97, 2015.

F. Bacchus and S. Schulman, Clinical experience with the new oral anticoagulants for treatment of venous thromboembolism, Arterioscler Thromb Vasc Biol. mars, vol.35, issue.3, pp.513-522, 2015.

N. Van-es, M. Coppens, S. Schulman, S. Middeldorp, and H. R. Büller, Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials, Blood. 18 sept, vol.124, issue.12, pp.1968-75, 2014.